Sisram Medical Ltd. provided earnings guidance for the six months ended June 30, 2020. For the unaudited consolidated management accounts of the Company for the six months ended June 30, 2020 and the information currently available to the Board, the revenue of the company for the period is expected to decrease by approximately 16%, the company's profit for the period is expected to decrease by approximately 58%. The decrease in the Profit is mainly attributable to the outbreak of the COVID-19 pandemic which has had a significant impact on the global medical aesthetics industry.